Alpha Teknova, Inc. (TKNO) vs Tilray Brands, Inc. (TLRY)

Alpha Teknova, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $474.4M against $408.0M — 1.2× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 12.3%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −38.4%) and the higher return on invested capital (−3.21% vs −16.9%). Across the 18 metrics below, Tilray Brands, Inc. leads on 11 and Alpha Teknova, Inc. on 7.

Valuation

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 8.69 0.42 2.11
P/B 6.07 0.25 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 8.69 0.56 2.73
Earnings yield (4.38%) (45.40%) (4.38%)
Free cash flow yield (1.94%) (43.04%) 0.00%

Profitability

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Gross margin 34.60% 29.12% 53.94%
Operating margin (36.19%) (9.26%) 0.00%
Net margin (38.37%) (17.05%) 0.00%
Free cash flow margin (16.83%) (18.11%) 0.00%
Return on equity (24.19%) (10.50%) (0.40%)
Return on assets (16.25%) (7.45%) (3.32%)
Return on invested capital (16.93%) (3.21%) 0.00%

Growth

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 12.27% 15.93% 10.01%
EPS growth (last fiscal year) 43.86% 95.57% 49.06%
Revenue growth, 5-year CAGR 5.30% 7.82% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.21 0.22 0.05
Current ratio 4.49 1.88 2.31
Net debt to EBITDA 0.75 11.34 0.97

Dividend

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Market cap 408.03m 474.40m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack